Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Trinucleotide repeat containing 18 pseudogene 3 (TNRC18P3) is a human pseudogene related to the gene TNRC18. It does not encode a protein product and is not considered a molecular therapeutic target. While the protein-coding gene TNRC18 is studied as a chromatin regulator with emerging epigenetic relevance (e.g., regulation of endogenous retroviruses and histone mark recognition)[4][2], TNRC18P3 itself lacks documented function, disease relevance, or interaction with drugs[1][7]. Note: TNRC18P3 is distinct from the protein-coding gene TNRC18. If the intent is to focus on a functional molecular target for drug discovery, refer instead to the canonical gene TNRC18 (trinucleotide repeat containing 18)[1][9][10].
None applicable for pseudogenes.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Trinucleotide repeat containing 18 pseudogene 3 (TNRC18P3).